gastrin-14 (Human) [3619]
gastrin-14 (Human)
| SMILES | CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |
| InChIKey | SSBRJDBGIVUNDK-QOGDCIHTSA-N |
| Sequence | WLEEEEEAYGWMDF |
| HELM | PEPTIDE1{W.L.E.E.E.E.E.A.Y.G.W.M.D.F.[am]}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | 23 |
| Hydrogen bond donors | 24 |
| Rotatable bonds | 57 |
| Log P | -2.010 |
| Molecular weight (Da) | 1831.7 |
| Stereochemistry info | unspecified |
No bioactivity data available.
gastrin-14 (Human)
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Endogenous |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0